GE HealthCare Technologies (NASDAQ:GEHC) CFO Acquires $200,586.00 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 1st. The shares were acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $61.03 on Monday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The business has a 50-day simple moving average of $73.28 and a 200 day simple moving average of $77.60. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The stock has a market cap of $27.76 billion, a price-to-earnings ratio of 14.60, a PEG ratio of 1.37 and a beta of 0.75.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the previous year, the firm earned $1.01 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.88 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.35%.

Key Stories Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders are buying shares — CEO Peter Arduini, CFO James Saccaro and director Frank R. Jimenez increased positions (multiple Form 4 filings), which investors often interpret as management confidence in the company’s outlook. Read More. • Read More. • Read More.
• Positive Sentiment: Heavy call-option buying — an unusual surge in call volume suggests short-term bullish/speculative interest that can amplify upside moves. (No article link available)
• Neutral Sentiment: Wells Fargo lowered its price target to $75 but kept an overweight rating, signaling upside exists vs. current levels while tempering near-term expectations. Read More.
• Neutral Sentiment: Operational changes — GEHC announced a reorganization (Imaging + Advanced Visualization) and executive moves intended to improve execution; benefits could take multiple quarters to materialize. Read More.
• Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS guidance to $4.80–5.00, citing inflation, higher component and freight costs and supply issues; this is the core reason for recent downside pressure. Read More.
• Negative Sentiment: Mixed Q1 results — revenue beat (~$5.13B) but EPS missed ($0.99 vs. $1.07 est.) and margins compressed, reinforcing short?term risk to earnings. Read More.
• Negative Sentiment: Analyst downgrades / price?target cuts — Citigroup, JPMorgan and others trimmed targets and ratings (e.g., PTs cut to ~$65–75), pulling sell?side support lower and contributing to volatility. Read More.
• Negative Sentiment: Investor litigation inquiry — a Johnson Fistel investigation adds headline and legal risk that could increase volatility. Read More.

Analysts Set New Price Targets

GEHC has been the subject of several research reports. JPMorgan Chase & Co. cut their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Thursday. Morgan Stanley upped their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Oppenheimer reiterated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and a consensus target price of $80.67.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently bought and sold shares of the stock. E Fund Management Hong Kong Co. Ltd. increased its stake in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies in the 4th quarter worth approximately $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Finally, Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.